Client Alerts
Biotechnology & Pharmaceutical
February 15, 2012
FDA Issues Long-Awaited Draft Guidance Documents Regarding Biosimilars
September 2, 2011
Federal Circuit Clarifies the Patent Eligibility of Medical Methods in Light of Bilski
August 9, 2011
Federal Circuit Upholds Claims to Isolated DNA Molecules
June 23, 2011
Patent Reform Passes the House
April 21, 2011
Biotech Life Science Trade Mission to China
March 26, 2010
Biosimilar Provisions Enacted in Health Care Bill
March 24, 2010
Federal Circuit Reaffirms The Existence Of A Written Description Requirement Separate From The Enablement Requirement
April 15, 2009
Federal Circuit Applies KSR to Biotechnology Patent Case
